By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    benefits of using protein powder to build muscles
    Protein Powder for Muscle Mass: Everything You Need to Know
    December 12, 2021
    changes brought on by blockchain in healthcare
    Technology In The Healthcare Industry
    March 28, 2022
    What Does Core Body Temperature Say About Health?
    August 17, 2022
    Latest News
    How to Recognize the Signs of Hormonal Imbalance in Men
    May 27, 2023
    4 Signs It’s Time to See a Therapist
    May 24, 2023
    11 Ways To Modernize Your Private Practice
    May 17, 2023
    Important Steps to Take for Scaling A Biopharma Product
    May 2, 2023
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    Changing Behavior to Conquer Obesity
    September 23, 2012
    Same Day Doctor Appointments? Read the Fine Print
    February 4, 2013
    Steady as She Goes or Down With the Ship, a Parable for Healthcare
    June 17, 2013
    Latest News
    MRI Sedation Options: What You Should Know Before Screening
    May 17, 2023
    What is the Process of Creating Medicine from Nature?
    May 2, 2023
    Choosing the Right Treatment Option for Varicose Veins
    May 2, 2023
    What Are Wrong-Site Surgeries and How Do They Occur?
    April 27, 2023
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: BioPharma Beat: 23andMe – Now What?
Share
Sign In
Notification Show More
Aa
Health Works CollectiveHealth Works Collective
Aa
Search
Have an existing account? Sign In
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Medical Ethics > BioPharma Beat: 23andMe – Now What?
DiagnosticsMedical EthicsMedical InnovationsPolicy & LawWellness

BioPharma Beat: 23andMe – Now What?

David Davidovic
Last updated: 2013/12/04 at 9:00 AM
David Davidovic
Share
8 Min Read
23andMe FDA warning
SHARE

23andMe FDA warningBy now everyone has heard of the very pointed and frustration-toned warning letter that 23andMe received from the F.D.A., which ordered the company to immediately stop selling and marketing their consumer genetic testing service.  The question is: Now what?

23andMe FDA warningBy now everyone has heard of the very pointed and frustration-toned warning letter that 23andMe received from the F.D.A., which ordered the company to immediately stop selling and marketing their consumer genetic testing service.  The question is: Now what?

I first got a kit for this “health and ancestry” service back in 2011.  I recall the easy part, spitting into this special plastic tube, opening an online account, and then sending the tube to their lab via mail in a special box.  I also recall my great trepidation when a few weeks later I got an email letting me know my results were in and I was invited to see them online.   On the one hand, I was very curious to see the reports.  It was like opening a fortune cookie at the Chinese restaurant, curious but knowing that I could ignore or rationalize whatever fortune I got because it would be so generic and, we were told, was based on very early preliminary, extrapolated research.  Another part of me was much more apprehensive because this actual, personalized testing of my own DNA could tell me something I didn’t already know, but do so in a somewhat factual way – or at least as factual as statistical probability analysis can get. 

My memory of the exercise back then, as well as after getting notices of the follow-up surveys and new analyses based on new independent research, is one of unease.  But I always took them with a sense of curious disregard, not knowing what exactly to make of it all.  Should I be happy that my genetic-based risk for a cardiovascular event is low, even though my untreated LDL-cholesterol level and weight are both on the high side?  Should I worry and run to the doctor knowing I have a slightly elevated risk for Restless Leg Syndrome in my lifetime, even though I don’t know of any immediate family members who suffers or suffered of it, that I know of – not to mention that no one had heard of this syndrome 10 years ago? 

More Read

medical interpreters

The Vital Role of Medical Interpreting Services In Healthcare

What Are the Advantages of Urgent Care Facilities?
Not Knowing About Comparative Negligence Can Worsen Your Medical Debt
The Role Addiction Plays in Increasing the Risk of Traffic Accidents
Why You Should Never Sleep While Wearing Your Contacts

With all this hesitation and pondering of my own, I completely understand the concerns of the F.D.A.   There seems to be an implicit, and I think explicit, promise in the marketing of their service.  Even today, two weeks after being ordered to stop marketing the test, the landing page of 23andMe website still shouts:

  • “Carrier status: Find out if your children are at risk for inherited conditions, so you can plan for the health of your family. 
  • Health risks: Understand your genetic health risks.  Change what you can, manage what you can’t. 
  • Drug response:  Arm your doctor with information on how you might respond to certain medications.” 

And there is not one single word of the F.D.A. warning letter or even acknowledgement of the regulatory quandary this service finds itself in.  Basically, it could appear to some that the company is choosing to ignore or stonewall or maybe step-up the fight with the F.D.A.  The letter all subscribers got from the CEO and the press release I saw seem to show a sense of honest concern but not one of urgency.

No one argues with the innovative nature of what this company and others like it.  I believe that what they are doing and the knowledge they generate will help improve lives in the long run.  Also, no one argues that F.D.A. regulations have a hard time keeping up with advances in science, technology and medical needs and realities; some will say they are based on byzantine regulations.  Still, the Warning Letter included this clear statement “we still do not have any assurance that the firm has analytically or clinically validated the PGS for its intended uses, which have expanded from the uses that the firm identified in its submissions.”  Regardless of anyone’s views on innovativeness, regulation, freedom-of-speech, or freedom to know what our own DNA says, we still need to follow some basic principles:

  • All tests need to be accurate and both scientifically and clinically validated – a simple matter of trust and confidence
  • All marketing and communications must be truthful and fair-balanced to ensure reasonable expectations, safety and a reasonable expectation of value

Some argue that they are not actually diagnosing you or treating you so there is no harm at all.  The agency is not sure about that.  One example the F.D.A. brought up to underscore the potential impact of the test is the case of the BRCA gene mutation.  When present, this mutation identifies a woman as having a significantly high risk aggressive breast cancer.  Recall that the presence of this mutation prompted Angelina Jolie, and many other women, to go through a preventive double mastectomy.  No one is saying that people are rushing to this major surgery alternative after a simple test like 23andMe; however, a positive result can certainly precipitate a lot of worry and possible action – and what if the test is not very accurate and is reporting a high proportion of false positives?  I would think the F.D.A. is right in insisting proof of accurate testing.  I also think it is right to ask of this and other companies to be very clear and thorough on what and how it communicates information about the test; there is a lot of grey area and the potential for misinterpretation is high.

The implications are many and it is not a simple matter of telling the world the tests are scientifically accurate, as seems to be the case with company communications in the last few weeks.  There are many more pieces to the puzzle: basic science, laboratory practices, clinical application/implications, marketing, medical and patient education, insurance coverage/risk implications, public relations and, yes, regulatory management.

Still, I am very optimistic.  The potential value of genetic testing of this nature is very promising.  I am also thankful that this issue has come up, perhaps in a dramatic way.  Whether it is 23andMe or other current or future companies, we have the need and the right to expect accurate tests, as well as truthful and balanced information on which we can make our own decisions.  I consider this a beachhead decision and a key step in a path that will result in a better future state for companies in this space, for doctors, and definitely for patients.

TAGGED: 23andMe, diagnostics, FDA, genetics, pathFW, personalized medicine, precision-medicine

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
David Davidovic December 4, 2013
Share this Article
Facebook Twitter Copy Link Print
Share
Previous Article HIV Aggressive New HIV Strain In West Africa Develops Into AIDS More Rapidly
Next Article RSNA 2013 HIV research RSNA 2013: Advancing Towards an HIV Cure?

Stay Connected

1.5k Followers Like
4.5k Followers Follow
2.8k Followers Pin
136k Subscribers Subscribe

Latest News

How to Recognize the Signs of Hormonal Imbalance in Men
How to Recognize the Signs of Hormonal Imbalance in Men
Health May 27, 2023
nursing trends and predictions
Biggest Nursing Trends and Predictions for 2023
Nursing May 25, 2023
medical answering service
How Medical Answering Services Can Improve Patient Care
Technology May 25, 2023
healthy parenting
4 Ways Parents Can Raise a Healthy and Happy Child
Parenting May 25, 2023

You Might also Like

MRI sedation options
Global Healthcare

MRI Sedation Options: What You Should Know Before Screening

May 17, 2023
medicines from nature
Global Healthcare

What is the Process of Creating Medicine from Nature?

May 2, 2023
varicose veins treatments
Health

Choosing the Right Treatment Option for Varicose Veins

May 2, 2023
wrong-site surgery
Policy & Law

What Are Wrong-Site Surgeries and How Do They Occur?

April 27, 2023
//

We influence million of users and is the most authentic source of information on healthcare business and technology news.

Quick Links

  • About
  • Contact
  • Privacy
Subscribe

Subscribe to our newsletter to get our newest articles instantly!

Follow US

© 2008-2023 HealthWorks Collective. All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?